Cardiovascular Monitoring and Diagnostic Devices Market, By Product Type (ECG Monitoring Device, Holter Monitoring Device, ECG Stress Testing, Event Monitoring Devices), By End User (Hospital, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI4021

Pages :150

Formats :

Excel and PDF

Industry : Medical Devices

Cardiovascular Monitoring And Diagnostic Devices MarketSize and Trends

Global Cardiovascular Monitoring and Diagnostic Devices Market is estimated to be valued at US$ 2,955.1 million in 2023 and is expected to exhibit a CAGR of 10.8% during the forecast period (2023-2030).

Market Trends

Increasing prevalence of chronic diseases, new launches of monitoring devices, and strategies, like mergers, acquisitions, and collaboration are expected drive the global cardiovascular monitoring and diagnostic devices market growth over the forecast period. For instance, according to the data published by the national Center for Biotechnology Information on August 12, 2022, cardiovascular diseases are one of the leading causes of death worldwide. Long-term and real-time monitoring of cardiovascular parameters is necessary to detect deviations and provide timely early intervention. To this end, the development of flexible wearable/implantable sensors for real-time monitoring of various vital functions has attracted widespread interest among researchers. Among various sensors, mechanical sensors can reflect direct information about the pressure fluctuations of the cardiovascular system, which has the advantage of high sensitivity and appropriate flexibility.

Global Cardiovascular Monitoring and Diagnostic Devices Market– Drivers

Increasing acquisitions by key players is expected to drive the global cardiovascular monitoring and diagnostic devices market growth over the forecast period. For instance, on November 8, 2021, Royal Philips, a global company in health technology, announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services.